Literature DB >> 22594861

Adenomyosis: a challenge in clinical gynecology.

Anne Z Cockerham1.   

Abstract

Adenomyosis is a prevalent, benign gynecologic condition in which endometrial tissue invades the myometrium, causing myometrial inflammation and hypertrophy. Although some women with adenomyosis are asymptomatic, the condition often causes menorrhagia and dysmenorrhea. This article provides women's health providers with a review of causes and risk factors for developing adenomyosis, clinical presentations of women with the condition, diagnostic modalities and criteria, and medical and surgical treatment options.
© 2012 by the American College of Nurse-Midwives.

Entities:  

Mesh:

Year:  2012        PMID: 22594861     DOI: 10.1111/j.1542-2011.2011.00117.x

Source DB:  PubMed          Journal:  J Midwifery Womens Health        ISSN: 1526-9523            Impact factor:   2.388


  9 in total

1.  Diagnosis and Treatment of Endometriosis. Guideline of the DGGG, SGGG and OEGGG (S2k Level, AWMF Registry Number 015/045, August 2020).

Authors:  Stefanie Burghaus; Sebastian D Schäfer; Matthias W Beckmann; Iris Brandes; Christian Brünahl; Radek Chvatal; Jan Drahoňovský; Wojciech Dudek; Andreas D Ebert; Christine Fahlbusch; Tanja Fehm; Peter Martin Fehr; Carolin C Hack; Winfried Häuser; Katharina Hancke; Volker Heinecke; Lars-Christian Horn; Christian Houbois; Christine Klapp; Heike Kramer; Harald Krentel; Jan Langrehr; Heike Matuschewski; Ines Mayer; Sylvia Mechsner; Andreas Müller; Armelle Müller; Michael Müller; Peter Oppelt; Thomas Papathemelis; Stefan P Renner; Dietmar Schmidt; Andreas Schüring; Karl-Werner Schweppe; Beata Seeber; Friederike Siedentopf; Horia Sirbu; Daniela Soeffge; Kerstin Weidner; Isabella Zraik; Uwe Andreas Ulrich
Journal:  Geburtshilfe Frauenheilkd       Date:  2021-04-14       Impact factor: 2.915

Review 2.  The Role of Abnormal Uterine Junction Zone in the Occurrence and Development of Adenomyosis.

Authors:  Tingting Xie; Xiya Xu; Yi Yang; Cangui Wu; Xiaohan Liu; Lili Zhou; Yali Song
Journal:  Reprod Sci       Date:  2021-09-13       Impact factor: 2.924

Review 3.  Exposure to the environmental endocrine disruptor TCDD and human reproductive dysfunction: Translating lessons from murine models.

Authors:  Kaylon L Bruner-Tran; Juan Gnecco; Tianbing Ding; Dana R Glore; Virginia Pensabene; Kevin G Osteen
Journal:  Reprod Toxicol       Date:  2016-07-14       Impact factor: 3.143

4.  Incidence and Estimated Prevalence of Endometriosis and Adenomyosis in Northeast Italy: A Data Linkage Study.

Authors:  Caterina Morassutto; Lorenzo Monasta; Giuseppe Ricci; Fabio Barbone; Luca Ronfani
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

5.  Developmental Toxicant Exposure Is Associated with Transgenerational Adenomyosis in a Murine Model.

Authors:  Kaylon L Bruner-Tran; Antoni J Duleba; Hugh S Taylor; Kevin G Osteen
Journal:  Biol Reprod       Date:  2016-08-17       Impact factor: 4.285

6.  Clinicopathological characteristics and imaging findings to identify adenomyosis-related symptoms.

Authors:  Shogo Imanaka; Hiroshi Shigetomi; Naoki Kawahara; Hiroshi Kobayashi
Journal:  Reprod Med Biol       Date:  2021-08-22

Review 7.  [S2k guidelines for the diagnosis and treatment of endometriosis-Recommendations for pathology].

Authors:  Lars-Christian Horn; Anne Kathrin Höhn; Stefanie Burghaus; Sebastian Daniel Schäfer; Uwe Andreas Ulrich; Dietmar Schmidt
Journal:  Pathologe       Date:  2021-10-01       Impact factor: 1.011

Review 8.  Rodent Models of Experimental Endometriosis: Identifying Mechanisms of Disease and Therapeutic Targets.

Authors:  Kaylon L Bruner-Tran; Shilpa Mokshagundam; Jennifer L Herington; Tianbing Ding; Kevin G Osteen
Journal:  Curr Womens Health Rev       Date:  2018-06

9.  Miniaturized phased-array ultrasound and photoacoustic endoscopic imaging system.

Authors:  Maryam Basij; Yan Yan; Suhail S Alshahrani; Hamid Helmi; Timothy K Burton; Jay W Burmeister; Michael M Dominello; Ira S Winer; Mohammad Mehrmohammadi
Journal:  Photoacoustics       Date:  2019-07-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.